Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CRAFT: Intensive BP Control in AF
NCT04347330Recruiting
- Sponsor
- Beijing An Zhen Hospital
- Start
- Aug 2020
- Primary completion
- Jun 2024
- Countries
- 1
01
Overview
Randomised, open-label trial in Atrial fibrillation (AFib) and hypertension (HTN) (2 arms), sponsored by Beijing An Zhen Hospital. Primary endpoint: Hierarchical composite cardiovascular outcomes at 5 years. Started Aug 2020; status: recruiting.
02
Conditions
Atrial fibrillation (AFib)hypertension (HTN)
Beyond the preview
Go deeper on NCT04347330.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04347330.